{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:48:08Z","timestamp":1792788488307,"version":"4.5.0"},"reference-count":59,"publisher":"The Endocrine Society","issue":"11","license":[{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Patient-Centered Outcomes Research Institute","award":["BPS-2022C3-30268"],"award-info":[{"award-number":["BPS-2022C3-30268"]}],"id":[{"id":"https:\/\/ror.org\/014q65q44","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Patient-Centered Outcomes Research Institute","id":[{"id":"https:\/\/ror.org\/014q65q44","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Board of Governors or Methodology Committee"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>No studies have explored racial differences in atherosclerotic cardiovascular disease (ASCVD) in women with polycystic ovary syndrome (PCOS), which is now known as polyendocrine metabolic ovarian syndrome (PMOS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Compare ASCVD risk by race\/ethnicity among women with PMOS and determine whether social determinants of health (SDoH) drive associations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Cohort study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Optum's de-identified Clinformatics\u00ae Data Mart Database (2000-2022).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Women aged 18 to 50 with PMOS using PCOS International Classification of Diseases 9\/10 codes. Race\/ethnicity was categorized as White, Black, Asian, or Hispanic.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>None.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcome Measures<\/jats:title>\n                    <jats:p>Primary outcome was risk of composite ASCVD (coronary artery disease, cerebrovascular disease, peripheral artery disease). Secondary outcomes included each component. Adjusted hazard ratios (aHR) and 95% confidence intervals (CIs) were estimated using Cox proportional hazards models that were unadjusted (Model 1), adjusted for medical comorbidities (Model 2), and adjusted for comorbidities plus SDoH: homeownership, net worth, and education (Model 3).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The sample included 413 450 women with PMOS. Accounting for medical comorbidities (Model 2), Asian women with PMOS were at a lower risk for ASCVD compared with White women (aHR, .65; 95% CI, .56-.74), and Black (aHR, 1.10; 95% CI, 1.02-1.19) and Hispanic women (aHR, 1.21; 95% CI, 1.12-1.29) were at a higher risk. After adjusting for SDoH (Model 3), the findings for Asian and Hispanic women remained significant, whereas those for Black women did not. When looking at individual components of ASCVD, the higher risk for multiple components among Black women was no longer significant after controlling for SDoH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Racial differences exist in risk of ASCVD among women with PMOS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgag308","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T11:16:08Z","timestamp":1785237368000},"page":"e2403-e2416","source":"Crossref","is-referenced-by-count":2,"title":["Social determinants of health and cardiovascular disease in women with polyendocrine metabolic ovarian syndrome (PCOS\/PMOS)"],"prefix":"10.1210","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2445-4571","authenticated-orcid":false,"given":"Snigdha","family":"Alur-Gupta","sequence":"first","affiliation":[{"name":"Department of OBGYN, University of Rochester , Rochester, NY 14642 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia D","family":"DiTosto","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania , Philadelphia, PA 19104 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle R","family":"Busse","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania , Philadelphia, PA 19104 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3483-5527","authenticated-orcid":false,"given":"Jennifer","family":"Lewey","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, University of Pennsylvania Perelman School of Medicine , Philadelphia, PA 19104 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E","family":"Soffer","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, University of Pennsylvania Perelman School of Medicine , Philadelphia, PA 19104 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania , Philadelphia, PA 19104 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen","family":"Brensinger","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania , Philadelphia, PA 19104 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunni L","family":"Mumford","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania , Philadelphia, PA 19104 ,","place":["USA"]},{"name":"Department of OBGYN, Hospital of the University of Pennsylvania , Philadelphia, PA 19104 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuja","family":"Dokras","sequence":"additional","affiliation":[{"name":"Department of OBGYN, Hospital of the University of Pennsylvania , Philadelphia, PA 19104 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"issue":"4","key":"2026101520035509800_dgag308-B1","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.fertnstert.2023.07.025","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"120","author":"Teede","year":"2023","journal-title":"Fertil Steril"},{"issue":"9","key":"2026101520035509800_dgag308-B2","doi-asserted-by":"crossref","first-page":"e3369","DOI":"10.1210\/clinem\/dgab392","article-title":"Women with polycystic ovary syndrome have an increased risk of Major cardiovascular events: a population study","volume":"106","author":"Berni","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2026101520035509800_dgag308-B3","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ajog.2020.12.019","article-title":"Disparities in cardio metabolic risk between black and white women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"224","author":"Kazemi","year":"2021","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"2026101520035509800_dgag308-B4","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ajog.2021.07.032","article-title":"Comprehensive evaluation of disparities in cardiometabolic and reproductive risk between Hispanic and White women with polycystic ovary syndrome in the United States: a systematic review and meta-analysis","volume":"226","author":"Kazemi","year":"2022","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"2026101520035509800_dgag308-B5","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1001\/jamacardio.2021.1137","article-title":"State of the nation's cardiovascular health and targeting health equity in the United States: a narrative review","volume":"6","author":"Diaz","year":"2021","journal-title":"JAMA Cardiol"},{"issue":"8","key":"2026101520035509800_dgag308-B6","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1161\/CIR.0000000000001303","article-title":"2025 heart disease and stroke statistics: a report of US and global data from the American Heart Association","volume":"151","author":"Martin","year":"2025","journal-title":"Circulation"},{"issue":"7","key":"2026101520035509800_dgag308-B7","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1001\/jama.2021.13304","article-title":"Updated guidance on the reporting of race and ethnicity in medical and science journals","volume":"326","author":"Flanagin","year":"2021","journal-title":"JAMA"},{"key":"2026101520035509800_dgag308-B8","author":"CDC"},{"issue":"3","key":"2026101520035509800_dgag308-B9","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1161\/CIRCULATIONAHA.122.059174","article-title":"Racial and ethnic differences in all-cause and cardiovascular disease mortality: the MESA study","volume":"146","author":"Post","year":"2022","journal-title":"Circulation"},{"key":"2026101520035509800_dgag308-B10","doi-asserted-by":"crossref","unstructured":"Alur-Gupta SJD, Lewey J, Soffer D, et al \u00a02026. Dokras Data from: Supplementary Material for Social Determinants of Health and Cardiovascular Disease in Women with Polyendocrine metabolic ovarian syndrome. Zenodo. 10.5281\/zenodo.21627963.","DOI":"10.1210\/clinem\/dgag308"},{"issue":"4","key":"2026101520035509800_dgag308-B11","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2018.07.360","article-title":"Using the electronic medical record (EMR) for identifying women with polycystic ovary syndrome (PCOS)","volume":"110","author":"Conoscenti","year":"2018","journal-title":"Fertil Steril"},{"issue":"3","key":"2026101520035509800_dgag308-B12","doi-asserted-by":"crossref","first-page":"280.e1","DOI":"10.1016\/j.ajog.2020.08.048","article-title":"Postpartum complications increased in women with polycystic ovary syndrome","volume":"224","author":"Alur-Gupta","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"2026101520035509800_dgag308-B13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2022.100335","article-title":"Atherosclerotic cardiovascular disease risk assessment: an American society for preventive cardiology clinical practice statement","volume":"10","author":"Wong","year":"2022","journal-title":"Am J Prev Cardiol"},{"issue":"4","key":"2026101520035509800_dgag308-B14","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.12.005","article-title":"Geographic disparities in the incidence of stroke among patients with atrial fibrillation in the United States","volume":"28","author":"Claxton","year":"2019","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"3","key":"2026101520035509800_dgag308-B15","first-page":"A60","article-title":"Triangulating differential nonresponse by race in a telephone survey","volume":"4","author":"DeFrank","year":"2007","journal-title":"Prev Chronic Dis"},{"issue":"9","key":"2026101520035509800_dgag308-B16","doi-asserted-by":"crossref","first-page":"8756","DOI":"10.18632\/oncotarget.23985","article-title":"Coronary artery disease risk in young women with polycystic ovary syndrome","volume":"9","author":"Ding","year":"2018","journal-title":"Oncotarget"},{"issue":"5","key":"2026101520035509800_dgag308-B17","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1080\/10543406.2020.1757692","article-title":"The inverse-probability-of-censoring weighting (IPCW) adjusted win ratio statistic: an unbiased estimator in the presence of independent censoring","volume":"30","author":"Dong","year":"2020","journal-title":"J Biopharm Stat"},{"issue":"Suppl. 2","key":"2026101520035509800_dgag308-B18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/00333549141291S206","article-title":"The social determinants of health: it's time to consider the causes of the causes","volume":"129","author":"Braveman","year":"2014","journal-title":"Public Health Rep"},{"issue":"2","key":"2026101520035509800_dgag308-B19","doi-asserted-by":"crossref","DOI":"10.1093\/ije\/dyae038","article-title":"Causal inference, mediation analysis and racial inequities","volume":"53","author":"Stanaway","year":"2024","journal-title":"Int J Epidemiol"},{"issue":"12","key":"2026101520035509800_dgag308-B20","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1093\/aje\/kwac140","article-title":"Recommendations for using causal diagrams to study racial health disparities","volume":"191","author":"Howe","year":"2022","journal-title":"Am J Epidemiol"},{"issue":"7","key":"2026101520035509800_dgag308-B21","doi-asserted-by":"crossref","first-page":"e386","DOI":"10.1016\/S2468-2667(20)30077-3","article-title":"Education and wealth inequalities in healthy ageing in eight harmonised cohorts in the ATHLOS consortium: a population-based study","volume":"5","author":"Wu","year":"2020","journal-title":"Lancet Public Health"},{"issue":"6","key":"2026101520035509800_dgag308-B22","doi-asserted-by":"crossref","first-page":"e422","DOI":"10.1016\/S2468-2667(23)00081-6","article-title":"Social determinants of health and premature death among adults in the USA from 1999 to 2018: a national cohort study","volume":"8","author":"Bundy","year":"2023","journal-title":"Lancet Public Health"},{"key":"2026101520035509800_dgag308-B23"},{"issue":"1","key":"2026101520035509800_dgag308-B24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/ije\/dyy236","article-title":"Med4way: a Stata command to investigate mediating and interactive mechanisms using the four-way effect decomposition","volume":"48","author":"Discacciati","year":"2018","journal-title":"Int J Epidemiol"},{"issue":"17","key":"2026101520035509800_dgag308-B25","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1001\/jama.2012.14306","article-title":"Association of race and sex with risk of incident acute coronary heart disease events","volume":"308","author":"Safford","year":"2012","journal-title":"JAMA"},{"issue":"12","key":"2026101520035509800_dgag308-B26","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002568","article-title":"A Chinese immigrant paradox? Low coronary heart disease incidence but higher short-term mortality in western-dwelling Chinese immigrants: a systematic review and meta-analysis","volume":"4","author":"Jin","year":"2015","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"2026101520035509800_dgag308-B27","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1136\/heartjnl-2013-303605","article-title":"Paradoxically lower prevalence of peripheral arterial disease in South Asians: a systematic review and meta-analysis","volume":"100","author":"Sebastianski","year":"2014","journal-title":"Heart"},{"issue":"24","key":"2026101520035509800_dgag308-B28","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1001\/jama.2019.19365","article-title":"Prevalence of diabetes by race and ethnicity in the United States, 2011-2016","volume":"322","author":"Cheng","year":"2019","journal-title":"JAMA"},{"issue":"24","key":"2026101520035509800_dgag308-B29","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1016\/j.jacc.2021.06.017","article-title":"Race, ethnicity, hypertension, and heart disease: JACC focus seminar 1\/9","volume":"78","author":"Ogunniyi","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"13","key":"2026101520035509800_dgag308-B30","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.029765","article-title":"The role of social determinants of health in cardiovascular diseases: an umbrella review","volume":"12","author":"Teshale","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"2026101520035509800_dgag308-B31","doi-asserted-by":"crossref","first-page":"e699","DOI":"10.1016\/S3050-5038(26)00090-7","article-title":"Atherosclerotic cardiovascular disease risk in polyendocrine metabolic ovarian syndrome: a nationwide, US, claims-based, retrospective, longitudinal, cohort study","volume":"2","author":"Alur-Gupta","year":"2026","journal-title":"Lancet Obstet Gynaecol Women's Health"},{"issue":"3","key":"2026101520035509800_dgag308-B32","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.fertnstert.2023.01.031","article-title":"Racial and ethnic disparities in polycystic ovary syndrome","volume":"119","author":"VanHise","year":"2023","journal-title":"Fertil Steril"},{"issue":"3","key":"2026101520035509800_dgag308-B33","first-page":"305","article-title":"Comparison of metabolic syndrome elements in white and Asian women with polycystic ovary syndrome: results of a regional, American cross-sectional study","volume":"1","author":"Chahal","year":"2020","journal-title":"F S Rep"},{"issue":"4","key":"2026101520035509800_dgag308-B34","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1210\/jc.2005-2430","article-title":"Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome","volume":"91","author":"Lo","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026101520035509800_dgag308-B35","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvag063","article-title":"Social deprivation, race, and metabolic syndrome in patients with polycystic ovary syndrome","volume":"10","author":"Lee","year":"2026","journal-title":"J Endocr Soc"},{"issue":"2","key":"2026101520035509800_dgag308-B36","first-page":"230","article-title":"Racial differences in anxiety, depression, and quality of life in women with polycystic ovary syndrome","volume":"2","author":"Alur-Gupta","year":"2021","journal-title":"F S Rep"},{"issue":"3","key":"2026101520035509800_dgag308-B37","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.amepre.2010.05.012","article-title":"Socioeconomic disparities in adverse birth outcomes: a systematic review","volume":"39","author":"Blumenshine","year":"2010","journal-title":"Am J Prev Med"},{"issue":"3","key":"2026101520035509800_dgag308-B38","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1097\/AOG.0000000000005678","article-title":"ACOG committee statement No. 10: racial and ethnic inequities in obstetrics and gynecology","volume":"144","year":"2024","journal-title":"Obstet Gynecol"},{"issue":"5","key":"2026101520035509800_dgag308-B39","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1097\/AOG.0000000000005721","article-title":"Addressing social and structural determinants of health in the delivery of reproductive health care: ACOG committee statement No. 11","volume":"144","year":"2024","journal-title":"Obstet Gynecol"},{"issue":"11","key":"2026101520035509800_dgag308-B40","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.2105\/AJPH.2014.302135","article-title":"Race\/ethnicity, residential segregation, and exposure to ambient air pollution: the multi-ethnic study of atherosclerosis (MESA)","volume":"104","author":"Jones","year":"2014","journal-title":"Am J Public Health"},{"issue":"11","key":"2026101520035509800_dgag308-B41","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/ajh\/hpu061","article-title":"Disparities in access to care among US adults with self-reported hypertension","volume":"27","author":"Fang","year":"2014","journal-title":"Am J Hypertens"},{"issue":"2 Suppl","key":"2026101520035509800_dgag308-B42","first-page":"40","article-title":"Asian Americans and infertility: genetic susceptibilities, sociocultural stigma, and access to care","volume":"3","author":"Vu","year":"2022","journal-title":"F S Rep"},{"key":"2026101520035509800_dgag308-B43","volume-title":"Multiple Origins, Uncertain Destinies: Hispanics and the American Future","author":"National Research Council Panel on Hispanics in the United States"},{"issue":"27","key":"2026101520035509800_dgag308-B44","doi-asserted-by":"crossref","first-page":"E948","DOI":"10.1503\/cmaj.220274","article-title":"Who is Black? The urgency of accurately defining the Black population when conducting health research in Canada","volume":"194","author":"C\u00e9nat","year":"2022","journal-title":"CMAJ"},{"issue":"8","key":"2026101520035509800_dgag308-B45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105516","article-title":"Association of CVD candidate gene polymorphisms with ischemic stroke and cerebral hemorrhage in Chinese individuals","volume":"9","author":"Ou","year":"2014","journal-title":"PLoS One"},{"key":"2026101520035509800_dgag308-B46","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1091612","article-title":"Association between ACE I\/D genetic polymorphism and the severity of coronary artery disease in Vietnamese patients with acute myocardial infarction","volume":"10","author":"Tran","year":"2023","journal-title":"Front Cardiovasc Med"},{"issue":"15","key":"2026101520035509800_dgag308-B47","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.008740","article-title":"High triglycerides are associated with increased cardiovascular events, medical costs, and resource use: a real-world administrative claims analysis of statin-treated patients with high residual cardiovascular risk","volume":"7","author":"Toth","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"2026101520035509800_dgag308-B48","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2217\/fca-2020-0123","article-title":"Real-world analyses of patients with elevated atherosclerotic cardiovascular disease risk from the Optum Research Database","volume":"17","author":"Toth","year":"2021","journal-title":"Future Cardiol"},{"issue":"16","key":"2026101520035509800_dgag308-B49","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.030105","article-title":"Associations of oral contraceptive use with cardiovascular disease and all-cause death: evidence from the UK biobank cohort study","volume":"12","author":"Dou","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"2026101520035509800_dgag308-B50","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-082801","article-title":"Stroke and myocardial infarction with contemporary hormonal contraception: real-world, nationwide, prospective cohort study","volume":"388","author":"Yonis","year":"2025","journal-title":"BMJ"},{"issue":"4","key":"2026101520035509800_dgag308-B51","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/13543784.2023.2196010","article-title":"Metformin: evidence from preclinical and clinical studies for potential novel applications in cardiovascular disease","volume":"32","author":"Dihoum","year":"2023","journal-title":"Expert Opin Investig Drugs"},{"issue":"1","key":"2026101520035509800_dgag308-B52","doi-asserted-by":"crossref","first-page":"39.e1\u2013","DOI":"10.1016\/j.ajog.2023.04.010","article-title":"Incidence, prevalence, and trends in polycystic ovary syndrome diagnosis: a United States population-based study from 2006 to 2019","volume":"229","author":"Yu","year":"2023","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"2026101520035509800_dgag308-B53","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.cjco.2023.12.010","article-title":"Increased prevalence of adverse health outcomes across the lifespan in those affected by polycystic ovary syndrome: a Canadian population cohort","volume":"6","author":"Vine","year":"2024","journal-title":"CJC Open"},{"issue":"1","key":"2026101520035509800_dgag308-B54","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12933-018-0680-5","article-title":"Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome","volume":"17","author":"Glintborg","year":"2018","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"2026101520035509800_dgag308-B55","first-page":"604","article-title":"Delayed diagnosis and a lack of information associated with dissatisfaction in women with polycystic ovary syndrome","volume":"102","author":"Gibson-Helm","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"24","key":"2026101520035509800_dgag308-B56","doi-asserted-by":"crossref","first-page":"e454","DOI":"10.1161\/CIR.0000000000000936","article-title":"Call to action: structural racism as a fundamental driver of health disparities: a presidential advisory from the American Heart Association","volume":"142","author":"Churchwell","year":"2020","journal-title":"Circulation"},{"issue":"1","key":"2026101520035509800_dgag308-B57","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.121.007917","article-title":"Race, racism, and cardiovascular health: applying a social determinants of health framework to racial\/ethnic disparities in cardiovascular disease","volume":"15","author":"Javed","year":"2022","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"3","key":"2026101520035509800_dgag308-B58","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1161\/HYPERTENSIONAHA.123.21354","article-title":"Social determinants of health and disparities in hypertension and cardiovascular diseases","volume":"81","author":"Chaturvedi","year":"2024","journal-title":"Hypertension"},{"issue":"6","key":"2026101520035509800_dgag308-B59","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s10597-017-0131-x","article-title":"Incorporating patients' social determinants of health into hypertension and depression care: a pilot randomized controlled trial","volume":"53","author":"McClintock","year":"2017","journal-title":"Community Ment Health J"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgag308\/70386261\/dgag308.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/11\/e2403\/70386261\/dgag308.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/11\/e2403\/70386261\/dgag308.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:04:11Z","timestamp":1792109051000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/111\/11\/e2403\/8747349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":59,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,7,30]]},"published-print":{"date-parts":[[2026,10,16]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgag308","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,11]]},"published":{"date-parts":[[2026,7,30]]}}}